EXICURE INC (XCUR) Stock News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Mentions: NBIX STIM HSDT LIPO ...

Exicure Stock Soars Over 25% On Acquisition Of GPCR Therapeutics’ U.S. Unit: Retail Chatter Spikes

GPCR USA is noted for its work in developing cutting-edge treatments, including Opdivo, a widely used autoimmune disease therapy generating about $10 billion in annual revenue.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Mentions: IVA RIGL AZTR CHRO ...

CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc.

Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech

CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

XCUR Stock Earnings: Exicure Reported Results for Q2 2024

Exicure just reported results for the second quarter of 2024.

XCUR Stock Earnings: Exicure Reported Results for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Exicure (NASDAQ:XCUR) just reported results for the second quarter of 2024.Exic...

Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results

Exicure, Inc. Receives Extension from Nasdaq Hearings Panel

Exicure, Inc. Announces Proposed Settlement of Securities Class Action Litigation

Exicure, Inc. Announces 1-for-5 Reverse Stock Split

Exicure, Inc. Announces Additional Adjournment of Special Meeting and Information for Reconvened Special Meeting

Exicure, Inc. Announces Adjournment of Special Meeting and Information for Reconvened Special Meeting

Exicure, Inc. Reports Second Quarter 2024 Financial Results